Melanoma Clinical Trials

A listing of Melanoma medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

UPDATED

Birmingham Alabama 35243

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

UPDATED

Muscle Shoals Alabama 35661

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Birmingham Alabama 35294

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Birmingham Alabama 35243

A clinical trial to evaluate treatments using TLPLDC and Placebo for patients with Melanoma

Birmingham Alabama 35249

Patients are needed to participate in a clinical research study evaluating Talimogene Laherparepvec and Immediate surgical resection of melanoma lesion(s) for the treatment of Completely Resectable Stage IIIB, IIIC, or IVM1a Melanoma

View More ▼

Birmingham Alabama

Patients are needed to participate in a clinical research study of Nivolumab + INCB24360

Mobile Alabama 36608

A clinical research study of talimogene laherparepvec, pembrolizumab (MK-3475) and placebo for the treatment of Melanoma, Unresected Melanoma

Mobile Alabama 36608

A clinical trial seeking patients for a research study for the treatment of Melanoma, Unresectable (Stage III) Melanoma or Metastatic (Stage IV) Melanoma

Arizona

UPDATED

Goodyear Arizona 85338

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

UPDATED

Goodyear Arizona 85338

Patients are needed to participate in a clinical research study of TSR-022 and anti PD-1 antibody to evaluate Advanced or Metastatic Solid Tumors

UPDATED

Scottsdale Arizona 85259

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Chandler Arizona 85224

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

Goodyear Arizona 85338

A clinical trial to evaluate treatments using Dabrafenib 150 mg twice a day (BID), Rabeprazole 40 mg once daily (OD) and Rifampin 600 mg OD for patients with Cancer

View More ▼

Phoenix Arizona 85016

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Phoenix Arizona 85054

A clinical trial to evaluate treatments using TLPLDC and Placebo for patients with Melanoma

Phoenix Arizona 85054

A clinical trial to evaluate treatments using TLPLDC and Placebo for patients with Melanoma

Phoenix Arizona 85016

Patients are needed to participate in a clinical research study of nab-paclitaxel for Recurrent/ Refractory Solid Tumors

Phoenix Arizona 85032

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

Phoenix Arizona 85018

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

Scottsdale Arizona 85258

A clinical research study of MRX34 for the treatment of Primary Liver Cancer, Solid Tumors or Lymphoma

Scottsdale Arizona 85259

A clinical research study of MRX34 for the treatment of Primary Liver Cancer, Solid Tumors or Lymphoma

Scottsdale Arizona

A clinical trial to evaluate treatments using DCC-2618 for patients with Gastrointestinal Stromal Tumors, Aggressive Systemic Mastocytosis or Advanced Cancers

Scottsdale Arizona 85258

A clinical trial to evaluate treatments using LY3009120 capsule for patients With Advanced Cancer or Cancer That Has Spread to Other Parts of Their Body

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

Scottsdale Arizona 85259

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study evaluating PLX3397 and Pembrolizumab to treat Advance Melanoma and Other Solid Tumors

Tucson Arizona 85719

A clinical research study of CPI-444 and CPI-444 + atezolizumab

Tucson Arizona 85719

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

Arkansas

Fayetteville Arkansas 72703

A clinical trial seeking patients for a research study for the treatment of Melanoma, Unresectable (Stage III) Melanoma or Metastatic (Stage IV) Melanoma

Fayetteville Arkansas 72703

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

Hot Springs Arkansas 71913

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

Little Rock Arkansas 72205

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

Rogers Arkansas 72758

Patients are needed to participate in a clinical research study of vemurafenib and rifampin to evaluate Malignant Melanoma, Neoplasms

California

UPDATED

Duarte California 91010

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

UPDATED

La Jolla California 92093

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

UPDATED

La Jolla California 92037

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

UPDATED

Los Angeles California 90095

Patients are needed to participate in a clinical research study evaluating IMCgp100, durvalumab and tremelimumab for the treatment of Malignant Melanoma, Cutaneous Melanoma

UPDATED

Los Angeles California 90025

Patients are needed to participate in a clinical research study evaluating IMCgp100, durvalumab and tremelimumab for the treatment of Malignant Melanoma, Cutaneous Melanoma

View More ▼

UPDATED

Los Angeles California 90095-1694

Patients are needed to participate in a clinical research study evaluating SD-101 and Pembrolizumab for the treatment of Metastatic Melanoma

UPDATED

Orange California 92868

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

UPDATED

Palo Alto California 94305

Patients are needed to participate in a clinical research study evaluating SD-101 and Pembrolizumab for the treatment of Metastatic Melanoma

UPDATED

Panorama City California 91402

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

UPDATED

San Diego California 92093

Patients are needed to participate in a clinical research study evaluating SD-101 and Pembrolizumab for the treatment of Metastatic Melanoma

UPDATED

San Francisco California 94143

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

UPDATED

Santa Monica California 90403

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

UPDATED

Santa Rosa California 95403

A clinical trial to evaluate treatments using Entrectinib (RXDX-101) for patients with Solid Tumors

Duarte California 91010

A clinical trial to evaluate treatments using Abemaciclib for patients with Breast Cancer or Brain Metastases

Duarte California 91010

Patients are needed to participate in a clinical research study evaluating Talimogene Laherparepvec and Immediate surgical resection of melanoma lesion(s) for the treatment of Completely Resectable Stage IIIB, IIIC, or IVM1a Melanoma

Greenbrae California 94904

Patients are needed to participate in a clinical research study evaluating PLX3397 and Pembrolizumab to treat Advance Melanoma and Other Solid Tumors

La Jolla California 92037-0845

A clinical trial to evaluate treatments using Abemaciclib for patients with Breast Cancer or Brain Metastases